Mouse anti Human CD11b, conjugated with Biotin
Product Name : Mouse anti Human CD11b, conjugated with BiotinDescription : | Clone F6.2 | Isotype IgG2a | Product Type Single-Color Reagent | Units 100 Tests | Host Mouse |…
Mouse anti Human CD11b/C3
Product Name : Mouse anti Human CD11b/C3Description : | Clone Bear-1 | Isotype IgG1 | Product Type Primary Antibodies | Units 0.1 mg | Host Mouse (Balb/c) | Species Reactivity…
Mouse anti Human CD11a
Product Name : Mouse anti Human CD11aDescription : | Clone OFYS | Isotype IgG2a | Product Type Single-Color Reagent | Units 100 µg | Host Mouse | Species Reactivity Human…
Mouse anti Human CD11a, conjugated with PE
Product Name : Mouse anti Human CD11a, conjugated with PEDescription : | Clone OFYS | Isotype IgG2a | Product Type Single-Color Reagent | Units 100 Tests | Host Mouse |…
Mouse anti Human CD11a, conjugated with FITC
Product Name : Mouse anti Human CD11a, conjugated with FITCDescription : | Clone OFYS | Isotype IgG2a | Product Type Single-Color Reagent | Units 100 Tests | Host Mouse |…
Chicken anti Human Haemoglobin
Product Name : Chicken anti Human HaemoglobinDescription : | Product Type Primary antibodies | Units 0.1 mg | Host Chicken | Application ELISA Western BlottingBackground : Chickens were immunized with…
APM2 (CT)
Product Name : APM2 (CT)Description : | Product Type Blocking Peptide | Units 50 µg | Application Western BlottingBackground : Source : APM2 is an ~8kDa protein which until recently…
Mouse anti Human CD11a, conjugated with Biotin
Product Name : Mouse anti Human CD11a, conjugated with BiotinDescription : | Clone OFYS | Isotype IgG2a | Product Type Single-Color Reagent | Units 100 Tests | Host Mouse |…
DE8A1 residues 460E461Y to alanines attenuated the interaction involving
DE8A1 residues 460E461Y to alanines attenuated the interaction between PDE8A and Raf-1 as measured by coimmunoprecipitation. (B) Quadruple mutation of PDE8A1 residues 454 455 460 461 R R E Y…
E Fanconi anemia (FA)/HR pathway. Prior studies have demonstrated that
E Fanconi anemia (FA)/HR pathway. Earlier studies have demonstrated that this can be accomplished by treating cells with epidermal development aspect receptor inhibitors (103) or cyclindependent kinase inhibitors (104), which…